By inhibiting P‐gP, verapamil is capable of blocking many inflammatory mediating cytokines that contribute to the formation of nasal polyps (NP), including IL5, IL6 and thymic stromal lymphopoietin (TSLP), ultimately leading to TH2 production [6, 7]. The gene discussed is TSLP; the disease is Nasal polyposis.